Stockreport

Pharma Stock Roundup: PFE's 2025 Outlook, MRK & ABBV's M&A Deals [Yahoo! Finance]

Merck & Company, Inc. (new)  (MRK) 
Last merck & company, inc. (new) earnings: 4/28 06:45 am Check Earnings Report
US:NYSE Investor Relations: investors.merck.com/home/default.aspx
PDF Sanofi SNY and Teva Pharmaceutical's TEVA inflammatory bowel disease (IBD) study on their candidate, duvakitug (TEV'574), met its primary endpoints. Merck MRK inked an e [Read more]